起搏器囊袋渗液及血肿的临床分析

Clinical analysis on pocket effusion or hematoma

目的探讨起搏器植入术后囊袋渗液及血肿的相关危险因素,从而有效避免该并发症发生。方法回顾性分析华中科技大学同济医学院附属同济医院心血管内科2012年6月至2013年6月行起搏器植入术145例患者的临床资料及发生囊袋渗液及血肿的情况。结果 (1)本组145例,其中男81例,女64例,平均年龄(62.73±14.63)岁。13例(8.97%)为心脏同步化起搏(CRT)及心脏转复除颤器(ICD)植入术患者,132例(91.03%)为单腔起搏器及双腔起搏器植入术患者;(2)囊袋渗液及血肿18例(12.41%),其中大型起搏器(CRT、ICD)植入术、体质量指数22以下、过敏体质、合并糖尿病及血管疾病与囊袋渗液及血肿发生率密切相关(P<0.05)。结论囊袋渗液及血肿是起搏器植入术后常见的并发症,术前仔细排查危险因素,可有效避免并发症发生。

Objective To investigate the risk factors on pocket effusion, hematoma, and find the treatments to decrease complications. Methods The complete clinical data of 145 patients admitted to our hospital for pacemaker implantations between Jun 2012 and Jun 2013 were retrospectively studied, which included basic clinical data and the condition of pocket effusion and hematoma. Results （1）Among 145 cases, in which 81 cases were male, 64 cases were female, the average age was（ 62. 73 ± 14. 63）years, 13 patients （8. 97%）were implanted by cardiac pacemaker synchronized （CRT）and heart converting defibrillator （ICD）, 132 patients （91. 03% ）were implanted by normal sin‐gle chamber pacemaker or double chamber pacemaker. （2） The pocket effusion or hematoma was complicated in 18 cases （12. 41%）, and it was significantly related with large pacemaker （CRT or ICD）, lower than 22 of body mass in‐dex, allergy, history of diabetes and cardiovascular disease （P〈0. 05）. Conclusion Pocket effusion or hematoma after pacemaker surgery was relatively common complication. If the risk factors could be found before the implantation, the complications should be controlled effectively.